The Egyptian Drug Authority (EDA) has published the June 2025 edition of the Pharmaceutical Practices Journal, aimed at enhancing the competencies of professionals in pharmaceutical care. The journal features updated topics on drug therapy and pharmacy practices, along with awareness activities and community engagement initiatives, all presented in a concise format tailored to the time constraints and needs of healthcare providers.
This edition highlights the EDA’s efforts in public awareness and community involvement, offering brief and practical insights that align with the daily demands of healthcare professionals.
Key features of the issue include:
-
An overview of the Guidance Manual for Nuclear Pharmacy, detailing the essential skills and knowledge for safe and effective practice. It covers types of radiation, protection measures, radioactive waste, radiopharmaceuticals, and the role of the clinical pharmacist.
-
A summary of the European Society of Cardiology’s 2024 updates on atrial flutter and chronic coronary syndromes.
-
A recap of pharmaceutical care initiatives conducted between March and May 2025.
This publication reflects the EDA’s vision and leadership in advancing pharmaceutical services for patients, enhancing the professional capabilities of Egyptian pharmacists, and progressing toward unified pharmacy practices. It also continues the EDA’s efforts in issuing guidance documents and establishing clear references for the pharmacist’s role as a cornerstone of the healthcare system.